baber/WOPTO huggingface dataset:
Patent NZ-266776-A (NZ)
Title: 1-aryl cycloalkyl sulphide, sulphoxide and sulphone compounds, preparation and pharmaceutical compositions;
Inventor: HARRIS PAUL JOHN
IPC: A61P25/28
Filed: 1994-05-07
Abstract: PCT No. PCT/EP94/01494 Sec. 371 Date Dec. 22, 1995 Sec. 102(e) Date Dec. 22, 1995 PCT Filed May 7, 1994 PCT Pub. No. WO94/26704 PCT Pub. Date Nov. 24, 1994Compounds of formula I    <IMAGE>  I  and pharmaceutically acceptable salts thereof in which m is 0, 1 or 2; n is 2, 3, 4 or 5; X is carbonyl or a group of formula II    <IMAGE>  II  in which R5 is H or alkyl; Y is an alkylene chain optionally substituted by one or more alkyl groups; Z is an alkylene chain containing 2 to 5 carbon atoms optionally substituted by one or more alkyl groups; R is phenyl optionally substituted by one or more halo substituents or R is naphthyl; and R1 and R2, which are the same or different, are H, alkyl, or arylalkyl, provided that when R1 is benzyl, R2 is H or methyl; have utility in the treatment of depression, anxiety, Parkinson's disease, obesity, cognitive disorders, seizures, neurological disorders such as epilepsy, and as neuroprotective agents to protect against conditions such as stroke.
Patent NZ-309036-A (NZ)
Title: pyrazole or triazole - oxybenzyl alkoxyacrylic acid esters, process for producing them and their use as fungicides
Inventor: MULLER BERND
IPC: A01N43/56
Filed: 1996-05-13
Abstract: ompounds of formula (I) are claimed  wherein: n is 0, 1, 2, 3 or 4; R is nitro, cyano, halogen or optionally substituted alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy or, if n is greater than 1, additionally an optionally substituted bridge bonded to two adjacent ring atoms and which contains 3 to 4 members selected from a)	3 or 4 carbons or b)	1 to 3 carbons and 1 or 2 nitrogen, oxygen and/or sulphur atoms; it being possible for this bridge, together with the ring to which it is bonded, to form a partially unsaturated or aromatic radical; R1 and R2 are alkyl; R3 is a substituted pyrazole or triazole radical of the formulae (A.1) to (A.3), in which the bond marked À is the bond to oxygen and the indices and the substituents are as defined in the specification. A fungicidal composition containing the above compound is also claimed.
Patent NZ-309829-A (NZ)
Title: Vaccine composition containing polyribosylribitol phosphate and method for making same
Inventor: ARMINJON FRANCOIS
IPC: A61P31/12
Filed: 1996-05-24
Abstract: Vaccine compositions are disclosed which comprise at least one antigen formed by the capsular polysaccharide of Haemophilus influenzae type b or high molecular weight polyribosylribitol phosphate coupled to tetanus anatoxin.
Patent NZ-322325-A (NZ)
Title: A pesticidal formulation comprising a water soluble granule pesticide e.g. emamectin benzoate and a water soluble filler e.g. lactose and processes for its manufacture
Inventor: LESCOTA REGINA D
IPC: A01N25/12
Filed: 1996-11-04
Abstract: The present invention is directed to a pesticidal composition of a water-soluble pesticide and processes for its manufacture. More specifically, the invention relates to a soluble granule (SG) pesticidal formulation comprising a water-soluble pesticide and a water-soluble filler.  The present invention provides a pesticidal formulation with efficacy equal to the corresponding liquid formulation, yet with improved handler safety, such as lower eye irritation.
Patent NZ-325817-A (NZ)
Title: Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-beta-estradiol to the human organism
Inventor: ASMUSSEN BODO
IPC: A61L15/44
Filed: 1996-12-23
Abstract: A pharmaceutical preparation adhering to the skin, in particular a TTS, for the release of the active substance 17-beta-estradiol, the concentration of the estradiol contained therein in dissolved form being between its saturation concentration in equilibrium with a gas phase of less than 10% relative air humidity and its saturation concentration in equilibrium with a gas phase of more than 90% relative air humidity, in all matrix layers and, if present, also in an adhesive layer, characterized in that the estradiol quantity contained in the preparation amounts to at least three times the saturation solubility measured at 95% relative air humidity, and that the air enclosed in the package is adjusted to a relative air humidity between 5% and below 0.5%.
Patent NZ-333862-A (NZ)
Title: Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen
Inventor: GAST MICHAEL JAY
IPC: A61K31/57
Filed: 1997-07-23
Abstract: The specification provides for a method of contraception.  The method comprises administering to a female of child bearing age for 23-25 consecutive days: (i) a first phase combination of a progestin at a daily dosage of 40-500 mg trimegestone, 250 mg-4 mg dienogest, or 250 mg - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20 mg ethinyl estradiol for 3-8 days beginning on day 1 of the menstrual cycle. The same dosage of the progestin and estrogen combination is administered in each of the 3-8 days. (ii) a second phase combination of a progestin at a daily dosage of 40-500 mg trimegestone, 250 mg - 4 mg dienogest, or 250 mg- 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20 mg ethinyl estradiol, for 4-15 days, beginning on the day immediately following the last day of administration of the first phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days, and (iii) a third phase combination of a progestin at a daily dosage of 40-500 mg trimegestone, 250 mg - 4 mg dienogest, or 250 mg - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20 mg ethinyl estradiol, for 4-15 days beginning on the day immediately following the last day of administration of the second phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days  provided that the daily dosage of the combination administered in the first phase is not the same as the daily dosage of the combination administered in the second phase and that the daily dosage of the combination administered in the second phase is not the same as the daily dosage of the combination administered in the third phase.
Patent NZ-334134-A (NZ)
Title: Axial piston rotary internal combustion engine with an undulating cam track between spaced apart end plates
Inventor: MANTHEY STEVEN CHARLES
IPC: F02B57/00
Filed: 1997-08-11
Abstract: PCT No. PCT/AU97/00506 Sec. 371 Date Feb. 9, 1999 Sec. 102(e) Date Feb. 9, 1999 PCT Filed Aug. 11, 1997 PCT Pub. No. WO98/06932 PCT Pub. Date Feb. 19, 1998A rotary internal combustion engine (200) of the type having a rotor assembly (216) supported in a housing (210) for rotation about a longitudinal axis (217), the housing having two spaced apart end plates (212, 213) and the axis being the axis of rotation of an output shaft (218) operatively connected at one end to the rotor assembly, the other end being free and passing through an aperture in one of the end plates, the rotor assembly including a plurality of pistons (231 to 238) mounted for reciprocating movement in respective cylinders (228) arranged in spaced relation around the longitudinal axis, and cam follower means (254) operatively connected to each piston and adapted to coact with undulating cam track means (225) supported around the axis of rotation and between the end plates, characterized in that the undulating cam track means includes an annular track mounted to a support stem or shaft (219) disposed substantially centrally thereof and extending in the direction of the longitudinal axis, the support stem or shaft being supported at one end by the other of the end plates (213) and the axis of the annular cam track means being the axis of rotation of the rotor assembly.
Patent NZ-335018-A (NZ)
Title: Digital data information transmission rate dependent on distance between cellular stations
Inventor: ZEHAVI EPHRAIM
IPC: H04J13/00
Filed: 1997-10-27
Abstract: A method and apparatus for transmitting digital data in a cellular environment. Adjacent cells of the cellular system are prevented from simultaneously transmitting data. Because the noise from transmissions of adjacent cells is a primary source of interference, the transmission rate of power limited base stations can be dramatically increased when the noise from adjacent cells is eliminated. The transmissions to each subscriber station are made at a fixed transmission power level. However, the data rate of transmitted signals differs from one subscriber station to another depending the path loss differences. In a first exemplary embodiment, the data rate of transmissions to a subscriber station is determined by selecting an encoding rate for the transmitted signal while holding the symbol rate constant. In a second exemplary embodiment, the data rate of transmissions to a subscriber station is determined by selection a modulation format for the transmitted signal which directly changes the symbol rate of transmission to a subscriber station.
Patent NZ-502868-A (NZ)
Title: Vertical axis washing machine detergent dispensing louvred tub ring secured to wash tub
Inventor: TITUS JAMES W
IPC: D06F39/02
Filed: 2000-02-15
Abstract: Housing top 34 has additive dispensers 36, 38, 40. Tub ring 16 has louvered areas 92 forming drop zones through which wash additives are dispensed directly into the wash tub (not shown). This is stated to provide reduced noise and enhanced initial mixing of the additive without fluid splashing over.
Patent NZ-503428-A (NZ)
Title: A stable solution suitable for parenteral application containing 3-(1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione (EM 12) a thalidomide derivative at pH 5.5 or less
Inventor: GERMANN TIENO
IPC: A61K47/26
Filed: 2000-03-16
Abstract: A stable aqueous solution containing 3-(1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for parenteral administration, wherein the 3-(1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione is dissolved in an isotonic glucose solution and the pH of the solution is less than or equal to 5.5. Addition to 503428
Patent NZ-511735-A (NZ)
Title: Optical imaging system with aberration correcting means
Inventor: BEACH ALLAN DAVID
IPC: G02B27/64
Filed: 2001-05-15
Abstract: An optical system includes a front end 1, a rear end image relay 2, an image transfer means 5 adapted to image the aperture stop of the rear end image relay 2 to a position where it forms the entrance pupil of the optical imaging system, and aberration correcting means 6,7 including a lens 7 having an aspherical surface 7A being sufficiently aspherical that chromatic error introduced by lens 7 cancels at least a major part of the chromatic error introduced by the meniscus lens 6. The aberration correcting means may further include a multiple component lens 6C to also cancel chromatic error. The front and rear ends may include one or more mirrors in different configurations.
Patent NZ-512564-A (NZ)
Title: Pulsed combustion device having a discharge port with a return flow valve and a combustion chamber shaped as a helmholz resonator
Inventor: DE BOER WILHELMUS PETRUS HENRI
IPC: F23C15/00
Filed: 1999-12-29
Abstract: A pulsed combustion device (1) for used in an underground borehole comprises a substantially tubular combustion chamber (10) and separate fuel and oxidant supply conduits (2, 6) for supplying fuel and oxidant to the combustion chamber. One of said conduits has a fluid discharge port equipped with return flow limitation means (13) located at the upstream end of the chamber and the combustion chamber is shaped as a Helmholz resonator having a tailpipe section (15) of which the internal diameter is significantly smaller than the other parts of the combustion chamber.
Patent NZ-513316-A (NZ)
Title: Continuous strand electric fence with different voltage strands on common insulator
Inventor: REID PAUL CLIFFORD
IPC: A01K3/00
Filed: 2001-09-18
Abstract: To form an electric fence across a span, two conductive strands 23, 29 having different voltage potentials applied thereto are strung continuously and repeatedly between insulators 3, 4 on opposite sides of the span. Each strand passes through or through and around one or more insulators, and at least two strands at different voltage potentials pass through or around at least one common insulator 3b, 4c, 3d, 4e etc.
Patent NZ-515451-A (NZ)
Title: Pipe fitting
Inventor: BEEVER ANDREW
IPC: F16L21/04
Filed: 2000-05-15
Abstract: A pipe-fitting 2 comprises a socket for receiving a pipe portion 1. The socket comprises a mouth and a bores. The bore contains a retaining element 6 for retaining the pipe portion 1 within the socket and an annular seal 5 for sealing between the socket and the pipe portion 1. A sleeve 18 is, in use, situated within the socket, and comprises a radially inwardly directed flange 20 located in a region adjacent the seal 5, for protecting the seal 5 from the pipe portion 1 when it is inserted into the socket. The flange may be provided with a plain flat surface. Sleeve 18 may be formed from plastics (e.g. polypropylene, polybutylene) or metal (e.g. stainless steel). Sleeve 18 may be cylindrical and include hinged leaves 36 for accommodating different diameter pipes and defining camming surfaces for element 6. Sleeves may be colour coded or have other indicia to indicate respective diameters. Sleeve 18 may be injection moulded with the leaves in an open position. The sleeve 18 may be divided into halves (figures 5, 6 - not shown) instead of including leaves.
Patent NZ-516337-A (NZ)
Title: Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
Inventor: MADELMONT JEAN-CLAUDE
IPC: A61K31/7008
Filed: 2000-06-22
Abstract: Described are quaternary ammonium derivatives of compounds known to be useful in the treatment or diagnosis of disorders affecting cartilage. The compounds are of formulae (Ia) and (Ib) wherein M represents a molecule used in the treatment or diagnosis of cartilage disorders; R1, R2, and R3 represent an alkyl group, or R1, R2, and R3 together with the nitrogen atom form a saturated or unsaturated heterocycle; X represents a C1-6 alkyl chain in which one or several methylene groups may be replaced by S, O, -NR-, -CO-, -CONH-, -COO-, -SO-, or -SO2-; R4 represents an alkyl group; n = 0 or 1; Hal represents halogen, or the formula (Ib); The general formula F1 represents a molecule used in the treatment or diagnosis of cartilage disorders, the N atom optionally being part of a saturated or unsaturated heterocycle or may be linked through a double bond. The molecules used in the treatment or diagnosis of cartilage disorders are preferably Tenidap, Melphalan, Chlorambucil, Glucosamine, Piroxicam, or, for diagnosis, a (15ane)-N5 ring labelled with technetium.
Patent NZ-520486-A (NZ)
Title: Substituted amino acids as neutral sphingomyelinase inhibitors
Inventor: WACHTER MICHAEL P
IPC: A61K31/197
Filed: 2001-02-01
Abstract: Compounds of formulae I and II for use as a medicament for treating conditions associated mediated by neural sphingomyelinase
Patent NZ-523481-A (NZ)
Title: Mammalian gamete and embryo culture media supplement and method of using same
Inventor: GARDNER DAVID K
IPC: C12N5/073
Filed: 2001-06-09
Abstract: A supplement and a culture media useful for culturing mammalian gametes and embryonic tissue is described. The culture media comprises at least one of recombinant human albumin, fermented hyaluronan, and citrate. Because the constituents are produced from non-conventional sources, the culture medium is free from contaminants such as viruses, prions and endotoxins.
Patent NZ-530120-A (NZ)
Title: Aminoacetonitrile compounds for controlling endoparasites
Inventor: DUCRAY PIERRE
IPC: A61K31/277
Filed: 2002-06-14
Abstract: Disclosed is the use of compounds of formula I, for the control of endoparasitic pests in warm-blooded productive livestock and domestic animals, wherein: m is 1, 2 or 3, R1 is each independently alkyl, alkoxy, haloalkyl, haloalkoxy or halogen, and R2 is haloalkyl.
Patent NZ-533986-A (NZ)
Title: Osmotic delivery system
Inventor: BILLOTE ANNE MARTINE
IPC: A61K9/22
Filed: 2003-01-28
Abstract: An osmotic pharmaceutical tablet comprising: (a) a single-layer compressed core comprising (i) a non-ripening drug having a solubility per dose less than about 1 mL-1, (ii) a hydroxyethylcellulose having a weight-average, molecular weight from about 300,000 to about 2,000,000, and (iii) an osmagent, wherein said hydroxyethylcellulose is present in said core from about 2.0% to about 20% by weight and said osmagent is present from about 15% to about 75% by weight; (b) a water-permeable layer surrounding said core; and (c) at least one passageway within said layer (b) for delivering said drug to a fluid environment surrounding said tablet.
Patent NZ-537823-A (NZ)
Title: Cooler structure for surface cooling used in method of repairing windscreen of vehicle
Inventor: DAVIES CHRISTOPHER
IPC: F24V30/00
Filed: 2003-08-01
Abstract: A cooler structure is disclosed for use in cooling a surface (such as a vehicle windscreen) has a backing panel (2) and, supported on the backing panel, cooling medium (30) in heat transfer relationship with the backing panel (2). The structure (1) may have a displaceable flap (15) or the like through which a target zone of the surface may be accessed. The displaceable flap (15) or the like may carry cooling medium (30). This application is directed at repair of a vehicle windscreen using the disclosed apparatus.
Patent NZ-539617-A (NZ)
Title: Multi-layer transmucosal therapeutic system
Inventor: LRUMME MARKUS
Filed: 2003-11-04
Abstract: A film-shaped therapeutic system comprising at least two layers connected with each other for transmucosal administration of active substances is disclosed, wherein said at least two layers includes a mucoadhesive layer which is mucoadhesive in an aqueous environment and a backing layer comprising at least one polyacrylate layer and serving as an active substance reservoir, wherein at least one layer of said at least two layers of said system contains an active substance, and wherein said mucoadhesive layer swells in an aqueous media but is insoluble or poorly soluble in the aqueous media and contains a polymer mixture comprising at least one hydrophile, mucoadhesive polymer embedded or dispersed in a polymer matrix comprising at least one polyvinyl alcohol.
Patent NZ-539920-A (NZ)
Title: Simple biodiesel production device
Inventor: SHULZE TERRY
IPC: B65D1/18
Filed: 2003-10-14
Abstract: A hand held device to produce small amounts of biodiesel by a transesterfication process, having a funnel shaped outlet conduit and valve to decant stratified layers through the outlet when the device is titled, a system of level marks on the container for various selective amounts of feedstock and additives and for evaluating the process from the resulting amount of byproduct, and orifices for filling and venting. Tilting means are disclosed A chemical mixture to create a chemical reaction for the transesterfication process is disclosed.
Patent NZ-546005-A (NZ)
Title: Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance
Inventor: VAN DER ARK RICHARD
IPC: A23L29/00
Filed: 2004-09-29
Abstract: Disclosed is an additive for beverages and foodstuffs, which comprises (i) at least 0.5%, preferably at least 1.0%, by weight of dry matter, of pyrazine derivatives according to formula (I): wherein R1-R4 independently represent hydrogen; a hydroxyhydrocarbyl residue; an ester of a hydroxyhydrocarbyl residue; or an ether of a hydroxyhydrocarbyl residue; and at least one R1-R4 is a hydroxyhydrocarbyl residue or an ester or an ether thereof, and (ii) exhibits an absorption ratio A280/560 of at least 80, preferably of at least 250. Also disclosed is a method of manufacturing a beverage or foodstuff that is resistant to light induced flavour changes, said method comprising introducing said additive into the beverages or foodstuffs; and a process for the manufacture of such a light stabilising additive.
Patent NZ-551127-A (NZ)
Title: Helical fastener
Inventor: MOORE SIMON GARRY
Filed: 2006-12-20
Abstract: A fastening mechanism (1) including a head (2) and a shaft (3) fixed to one end of the head. At least part of the shaft is effectively threaded, and at least part of the shaft has no anchoring base for the thread (4). At least part of the shaft and at least part of the thread are together formed from at least one unbroken wound spiral.
Patent NZ-554952-A (NZ)
Title: Pyridine derivatives and the preparation and the therapeutic use thereof
Inventor: BARRE LIONEL
IPC: C07D401/12
Filed: 2005-10-17
Abstract: Disclosed are compounds of formula (I), wherein Z is a N(R1)XR2, N(R1)COOR'2 or OCON(R1)R'2 group; X is a -CO-, -SO2-, -CON(R10)- or -CSN(R10)-; R1 is a hydrogen atom or an (C1-C4) alkyl group; R2 is a (C3-C10) alkyl group, a (C3-C12) carboxylic non-aromatic radical, a heterocyclic radical, a non-substituted or substituted phenyl and a (C1-C2) alkylene substituted by one or two equal or different substituents; R3 is a hydrogen atom, or a (C1-C4) alkyl, cyano, (C1-C4) alkoxymethyl or hydroxymethyl group. Further disclosed are processes for preparing the compounds, and uses of the compounds in the preparation of medicaments for treating and preventing disorders including appetite disorders, metabolic disorders and gastro-intestinal disorders.
Patent NZ-561054-A (NZ)
Title: Aqueous insecticidal compositions and the use thereof for protecting lignocellulose-containing materials
Inventor: AMRHEIN PATRICK
IPC: A01N25/04
Filed: 2006-03-08
Abstract: Disclosed herein is an aqueous insecticidal composition characterized by an aqueous polymer fine particle dispersion containing at least one type of organic insecticidal active substance whose water solubility is not more than 5 g/l at 25 °C/1013 mbar and having a mean particle size, determined by dynamic light scattering, of not more than 500 nm, wherein the polymer particles containing at least one insecticidal active substance exhibits a positive surface charge and the aqueous dispersion of active substance containing polymer particles is obtained by radical aqueous emulsion polymerisation of an ethylenically unsaturated monomer composition M, in which said ethelenycally unsaturated monomer M contains at least one type of insecticidal active substance in a dissolved form. Also disclosed is the use of the aqueous insecticidal composition for protecting lignocellulose-containing materials, in particular wood, against attack by harmful insects.